Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid

• Deepak K. Kaushik,

  Affiliation Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Heather Y. F. Yong,

  Affiliation Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Jennifer N. Hahn,

  Affiliation Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Claudia Silva,

  Affiliation Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Steven Casha,

  Affiliation Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

  ⨯
• R. John Hurlbert,

  Affiliation Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Francois H. Jacques,

  Affiliation CSSSG-Hull Pavilion, Gatineau, Quebec, Canada

  ⨯
• Robert Lisak,

  Affiliation Multiple Sclerosis Center, Wayne State University School of Medicine, Detroit, Michigan, United States of America

  ⨯
• Omar Khan,

  Affiliation Multiple Sclerosis Center, Wayne State University School of Medicine, Detroit, Michigan, United States of America

  ⨯
• Carolina Ionete,

  Affiliation Multiple Sclerosis Center, University of Massachusetts, Worcester, Massachusetts, United States of America

  ⨯
• Catherine Larochelle,

  Affiliation University of Montreal, Montreal, Quebec, Canada

  ⨯
• Alex Prat,

  Affiliation University of Montreal, Montreal, Quebec, Canada

  ⨯
• Amit Bar-Or,

  Affiliation Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada

  ⨯
• V. Wee Yong

  * E-mail: vyong@ucalgary.ca

  Affiliation Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

  ⨯